Month: January 2022

Just published: This post hoc analysis compared #suprachoroidal triamcinolone ac…

Just published: This post hoc analysis compared #suprachoroidal triamcinolone acetonide (CLS-TA) to other commonly available treatments for non-infectious uveitis. #eyes #retina #xipere #uveitis https://t.co/0XXfZFwdPo Source by Thomas Ciulla, MD, MBA Return to main website.

RT @SEIO_uveitis: Un poco de lectura para esta víspera de reyes, compartimos el …

RT @SEIO_uveitis: Un poco de lectura para esta víspera de reyes, compartimos el siguiente artículo: Suprachoroidal triamcinolone acetonide… Source by Thomas Ciulla, MD, MBA Return to main website.

RT @RetinaToday: Wet AMD, DME, and RVO-ME are leading causes of legal blindness …


RT @RetinaToday: Wet AMD, DME, and RVO-ME are leading causes of legal blindness in the industrialized world. Data out to 5 years provide ne…


Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @ThomasCiullaMD: Just published: Long-Term Outcomes of Anti-VEGF Therapy. Tr…

RT @ThomasCiullaMD: Just published: Long-Term Outcomes of Anti-VEGF Therapy. Treatment burden is a barrier to real world #outcomes in #AMD… Source by Thomas Ciulla, MD, MBA Return to main website.